lifenews.com
2026-03-31
Just a little bit over ten months ago, the Ethics & Public Policy Center (EPPC) released a study which really upset the dominant media narrative about the safety of the abortion pill. While the abortion industry had used a few limited studies to convince the U.S. Food and Drug Administration (FDA) that serious complications were less than half a percent, EPPC looked at more than 865,000 insurance claims of actual mifepristone patients and determined that the serious adverse events rate was closer to 11%!
Abortion advocates attacked with a fury. They complained this wasn't one of their carefully controlled clinical studies, ignoring the fact that EPPC offered documentable, real world patient data, not the industry's hand-picked samples and spun data with its most problematic cases "lost to follow-up."
That was last year. Now, the team at EPPC is back with new data. This makes it plain that the latest changes the FDA made to the mifepristone protocol from abortion industry data - eliminating a required in-person office visit, allowing these pills to be ordered online and mailed to a woman's home without full screening or a physical exam - didn't make things safer, but more dangerous.
Woman Forced to Take Abortion Pills Speaks Out by Katelynn Richardson